ArticleMovement disorders clinical practice2026
Clinical Benefits of Reprogramming Chronic Subthalamic Stimulation in Parkinson's Disease.
Article in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundReprogramming of chronic deep brain stimulation (DBS) in Parkinson's disease is often underutilized despite potential clinical benefit.
objectiveThe aim was to assess the impact of systematic reprogramming in patients with long-term subthalamic nucleus (STN) DBS.
methodsTen patients with long-term STN-DBS underwent systematic reprogramming due to recurrence of motor symptoms or increased medication needs. Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III scores (medication off/DBS ON) and levodopa equivalent daily dose (LEDD) were compared across initial programming, pre-reprogramming, and post-reprogramming using repeated-measures analysis of variance (ANOVA).
resultsReprogramming yielded a significant 24% improvement in MDS-UPDRS Part III scores (P = 0.02) without significant LEDD change. Imaging revealed that reprogramming commonly engaged dorsolateral or supra-STN regions by increasing amplitude or changing from bipolar to monopolar settings while maintaining contact pairs.
conclusionsSystematic reprogramming can improve long-term motor outcomes in STN-DBS. Imaging may assist in understanding and guiding effective reprogramming strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.